|Bid||3.0200 x 1400|
|Ask||3.0100 x 800|
|Day's range||2.9600 - 3.3500|
|52-week range||1.8300 - 7.7300|
|Beta (5Y monthly)||1.75|
|PE ratio (TTM)||N/A|
|Earnings date||10 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||12.40|
Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of 11.11% and -7.30%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Clearside Biomedical, Inc. (CLSD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
We can readily understand why investors are attracted to unprofitable companies. Indeed, Clearside Biomedical...